Literature DB >> 26346695

The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review.

Mariangela Spano, Maria Signorelli, Roberta Vitaliani, Eugenio Aguglia, Bruno Giometto.   

Abstract

The hallmark of dementia with Lewy bodies (DLB) is the “Lewy body”, an abnormal aggregation of alpha-synuclein found in some areas of the brain. The brain is the organ/system that is most vulnerable to this oxidative damage, and reactive oxygen species can cause neurodegenerative diseases. Different models of mitochondrial deregulation have been compared in DLB. The results are consistent with the hypothesis that alpha-synuclein affects the mitochondria themselves, increasing their sensitivity or leading to cell death through protective (neurosin) and accelerating (cytochrome c) factors. This systematic review suggests that mitochondria play an important role in neurodegeneration and a crucial role in the formation of Lewy bodies. DLB is a disease characterized by abnormal accumulation of alpha-synuclein that could result in the release of cytochrome c and subsequent activation of the apoptotic cascade.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26346695      PMCID: PMC4610749          DOI: 10.11138/fneur/2015.30.3.151

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  72 in total

Review 1.  Protein aggregation in crowded environments.

Authors:  R John Ellis; Allen P Minton
Journal:  Biol Chem       Date:  2006-05       Impact factor: 3.915

Review 2.  Hero versus antihero: the multiple roles of alpha-synuclein in neurodegeneration.

Authors:  Mark R Cookson
Journal:  Exp Neurol       Date:  2006-05-09       Impact factor: 5.330

3.  The regulation of synaptic function by alpha-synuclein.

Authors:  Serena Bellani; Vitor L Sousa; Giuseppe Ronzitti; Flavia Valtorta; Jacopo Meldolesi; Evelina Chieregatti
Journal:  Commun Integr Biol       Date:  2010-03

Review 4.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

Review 5.  Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.

Authors:  Michael J Volles; Peter T Lansbury
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

6.  Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis.

Authors:  Yang-ja Lee; Seon-Yong Jeong; Mariusz Karbowski; Carolyn L Smith; Richard J Youle
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

Review 7.  The role of mitochondria in apoptosis*.

Authors:  Chunxin Wang; Richard J Youle
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

8.  Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.

Authors:  J Eric Ahlskog
Journal:  Parkinsonism Relat Disord       Date:  2009-10-07       Impact factor: 4.891

Review 9.  Cell systems and the toxic mechanism(s) of alpha-synuclein.

Authors:  Mark R Cookson; Marcel van der Brug
Journal:  Exp Neurol       Date:  2007-06-04       Impact factor: 5.330

Review 10.  Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?

Authors:  V Bogaerts; J Theuns; C van Broeckhoven
Journal:  Genes Brain Behav       Date:  2007-08-03       Impact factor: 3.449

View more
  5 in total

1.  Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.

Authors:  Ching-Chi Chang; Hsin-Hua Li; Yen-Ting Chang; Ying-Jui Ho; Ling-Jia Hsieh; Pai-Yi Chiu; Yu-Shih Cheng; Chih-Li Lin; Te-Jen Lai
Journal:  CNS Neurosci Ther       Date:  2017-11-01       Impact factor: 5.243

Review 2.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 3.  Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs.

Authors:  Devesh Tewari; Adrian M Stankiewicz; Andrei Mocan; Archana N Sah; Nikolay T Tzvetkov; Lukasz Huminiecki; Jarosław O Horbańczuk; Atanas G Atanasov
Journal:  Front Aging Neurosci       Date:  2018-02-12       Impact factor: 5.750

Review 4.  The Protective Role of Neurogenetic Components in Reducing Stress-Related Effects during Spaceflights: Evidence from the Age-Related Positive Memory Approach.

Authors:  Nicola Mammarella; Matteo Gatti; Irene Ceccato; Adolfo Di Crosta; Alberto Di Domenico; Rocco Palumbo
Journal:  Life (Basel)       Date:  2022-08-02

Review 5.  MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.

Authors:  Ahmad R Arshad; Siti A Sulaiman; Amalia A Saperi; Rahman Jamal; Norlinah Mohamed Ibrahim; Nor Azian Abdul Murad
Journal:  Front Mol Neurosci       Date:  2017-10-31       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.